Ingenix looks to buy A-Life Medical

Mary Stevens | | Health Exec | Economics
Ingenix, UnitedHealth Group’s health IT subsidiary, will acquire A-Life Medical, a San Diego-based provider of computer-assisted coding (CAC) products and services for the healthcare industry, for an undisclosed amount.

A-Life will become part of the Ingenix Health Care Delivery business, according to Ingenix, of Eden Prairie, Minn. The acquisition follows the alliance Ingenix and A-Life established last year to develop coding technologies for the healthcare market.

Ingenix provides medical coding research and encoding tools for hospitals and physician practices. A-Life Medical provides CAC software. Together, the companies will develop coding technologies for all billing services providers, physician practices and inpatient and outpatient providers, as well as for more medical specialties, according to Ingenix.

A-Life’s LifeCode, a natural language processing (NLP) technology, assists medical coders and clinical abstractors through software applications, including Actus, A-Life’s CAC product. LifeCode reads clinical documentation, deciphers the meaning and context of words within medical records and correctly identifies diagnoses and procedures provided during patient care. The software then recommends appropriate and compliant ICD-9 and CPT-4 codes. Coding staff can confirm the suggested codes, conduct additional research to validate them or adjust them.

This acquisition is the fourth for Ingenix in 2010. the company has acquirred Picis, Executive Health Resources and Axolotl.

Mary Stevens

Related Content

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward
UnitedHealth pushes back against shareholder transparency proposal
Thousands of staff cut from federal health agencies, including CDC and VA
Nonprofit academic hospital receives criticism after running Super Bowl ad
HeartBeam raising $10M for FDA-cleared health tech with public offering

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”